Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024

Ahead of exhibiting at the 2024 DIA Global Annual Meeting, Qinecsa spoke with industry leading journal Outsourcing Pharma about the company’s latest breakthrough in clinical research technology, how it addresses the current challenges in the industry, and the major trends that will shape the future of pharmaceuticals.

Qinecsa discusses the vast volumes of data and trial complexity requiring new ways of working, leveraging AI, to move pharmacovigilance (PV) from being a necessary, safety and cost-saving function to a proactive, value-creation function.

Challenges facing the PV sector are considered, including outdated, costly and labor-intensive processes, and inconsistent reporting structures from parallel safety organizations further increasing complexity.

Opportunities are noted through platform approaches and advanced technology to consolidate global operations and centralize reporting structures. But all this needs to be underpinned by the right culture and processes, with strong leadership based on data-driven decisions, consistent measurement of progress and a continuous cycle of improvement.

The discussion covers the recent acquisition of Insife – a well-established software, technology, and consultancy firm – which has strengthened Qinecsa’s capabilities in software development. This has enhanced the company’s existing pharmacovigilance (PV) services and accelerated innovation, providing faster solutions for clients and most critically improving patient safety.

Qinecsa’s DIA 2024 showcase will include a range of industry-leading technologies which support the PV landscape, including:
  • the Reportum Platform, a unified adverse event platform managing both digital and analogue reports across global sources and languages, delivering a digital-first experience.
  • the Commonwealth Vigilance Workbench (CVW), a signal detection platform enabling analysis of aggregate data from multiple adverse event datasets. Supported by configurable planning and workflow capabilities, this ensures all potential signals are tracked with clear prioritization.
  • the HALOPV Platform which manages all multi-vigilance processes, from operational to scientific, in the world’s first fully comprehensive and cohesive solution.
To learn more, read the full interview here: